Journal profile · Neurosciences
Journal of Molecular Neuroscience
ISSN 0895-8696 · eISSN 1559-1166 · Springer US · UNITED STATES · Monthly · Founded 1989
Journal of Molecular Neuroscience: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.46; hybrid open access; APC about USD 4,990; median 67 days to acceptance (97 articles, last 24 months); community-reported acceptance: easy; 165 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Molecular Neuroscience is published by Springer US and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neuroscience and Neuropharmacology Research, Alzheimer's disease research and treatments and Neuropeptides and Animal Physiology, together about 26.5% of its articles. Its main subfields are Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Molecular Neuroscience is committed to the rapid publication of original findings that increase our understanding of the molecular structure, function, and development of the nervous system. The criteria for acceptance of manuscripts will be scientific excellence, originality, and relevance to the field of molecular neuroscience. Manuscripts with clinical relevance are especially encouraged since the journal seeks to provide a means for accelerating the progression of basic research findings toward clinical utilization. All experiments described in the Journal of Molecular Neuroscience that involve the use of animal or human subjects must have been approved by the appropriate institutional review committee and conform to accepted ethical standards.
From the journal's Aims & Scope
Research area (LetPub): Neurosciences
Editor-in-chief Illana GozesPublisher website
Editorial board by country: 3 in mainland China (about 4%); most named United States 36, Israel 14, United Kingdom 6, Germany 4, France 4 (82 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroscience and Neuropharmacology ResearchNeuroscience9.5%
- Alzheimer's disease research and treatmentsMedicine9%
- Neuropeptides and Animal PhysiologyNeuroscience8%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience7.2%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology6.4%
- Nerve injury and regenerationNeuroscience5.1%
- Neurogenesis and neuroplasticity mechanismsNeuroscience4.9%
- Parkinson's Disease Mechanisms and TreatmentsMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.46LetPub ·
- Impact factor (publisher) 2025
- 2.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.9Publisher website ·
- CiteScore 2026-06
- 5.5LetPub ·
- SJR 2026-06
- 0.79LetPub ·
- SNIP 2026-06
- 0.6LetPub ·
- h-index
- 79LetPub ·
- h-index
- 118OpenAlex ·
- i10-index
- 3,081OpenAlex ·
- 2-year mean citedness
- 2.68OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 20.7%LetPub ·
Volume
- Articles per year
- 159LetPub ·
- Downloads per year (publisher) 2025
- 693,000Publisher website ·
Articles by year OpenAlex count · 4,612 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 141 | 32 | 47 |
| 2025 | 165 | 40 | 473 |
| 2024 | 118 | 32 | 616 |
| 2023 | 74 | 21 | 475 |
| 2022 | 155 | 42 | 2,133 |
| 2021 | 185 | 44 | 3,425 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
67 daysMedian, submission to acceptance · P25–P75 48 days – 106 days
- Acceptance to online
- median 14 days (97 articles)
- Submission to online
- median 90 days
- Sample
- 97 articles with submission and acceptance dates (335 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,990 / EUR 3,890 / GBP 3,090 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Author–date
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
Article types accepted4
- editorialOriginal Research: Full−length reports containing complete details of methods and procedures Review: Solicited or unsolicited articles which present either an e…Length not stated
- literature reviewOriginal Research: Full−length reports containing complete details of methods and procedures Review: Solicited or unsolicited articles which present either an e…Length not stated
- original researchOriginal Research: Full−length reports containing complete details of methods and procedures Review: Solicited or unsolicited articles which present either an e…Length not stated
- reviewOriginal Research: Full−length reports containing complete details of methods and procedures Review: Solicited or unsolicited articles which present either an e…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Journal of Molecular Neuroscience, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1989
- ISSN
- 0895-8696
- Electronic ISSN
- 1559-1166
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Molecular Neuroscience
What CAS zone is Journal of Molecular Neuroscience in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Molecular Neuroscience is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Neurosciences. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Molecular Neuroscience?
The latest impact factor listed by LetPub is 2.46; CiteScore 5.5, h-index 118.
How long does peer review take at Journal of Molecular Neuroscience?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 67 days (interquartile range 48–106 days); authors report an average review time of about 1 month; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Molecular Neuroscience?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Author–date; Templates: Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Molecular Neuroscience based?
Of the 82 board members whose country the journal's board page names, 3 (about 4%) are in mainland China; the countries named most often are United States (36), Israel (14) and United Kingdom (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Molecular Neuroscience?
According to LetPub and DOAJ records, Journal of Molecular Neuroscience is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Journal of Molecular Neuroscience open access, and what is the APC?
Journal of Molecular Neuroscience is a hybrid journal. For open-access publication: APC about USD 4,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .